Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma
- PMID: 30282914
- PMCID: PMC6213422
- DOI: 10.3390/ijms19103014
Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma
Abstract
Despite the significant recent achievements in the diagnosis and treatment of colorectal cancer (CRC), the prognosis of these patients has currently plateaued. During the past few years, the opportunity to consider multiple treatment modalities (including surgery and other locoregional treatments, systemic therapy, and targeted therapy) led to the research of novel prognostic and predictive biomarkers in CRC liver metastases (CRCLM) patients. In this review, we seek to describe the current state of knowledge of CRCLM biomarkers and to outline impending clinical perspectives, in particular focusing on the cutting-edge tools available for their characterization.
Keywords: biomarkers; colorectal cancer; immunohistochemistry; liver metastases; molecular markers; predictive; prognostic.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.Oncotarget. 2017 May 30;8(22):35783-35791. doi: 10.18632/oncotarget.16206. Oncotarget. 2017. PMID: 28415758 Free PMC article.
-
Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.Oncotarget. 2016 Aug 2;7(31):50428-50436. doi: 10.18632/oncotarget.10416. Oncotarget. 2016. PMID: 27391432 Free PMC article.
-
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.Br J Cancer. 2014 Aug 12;111(4):749-55. doi: 10.1038/bjc.2014.354. Epub 2014 Jul 1. Br J Cancer. 2014. PMID: 24983372 Free PMC article.
-
Predictive markers of colorectal cancer liver metastases.Future Oncol. 2011 Feb;7(2):299-307. doi: 10.2217/fon.10.184. Future Oncol. 2011. PMID: 21385143 Review.
-
Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer.Microrna. 2018;7(3):167-177. doi: 10.2174/2211536607666180525073302. Microrna. 2018. PMID: 29793419 Review.
Cited by
-
Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.Int J Mol Sci. 2019 Oct 3;20(19):4915. doi: 10.3390/ijms20194915. Int J Mol Sci. 2019. PMID: 31623387 Free PMC article. Review.
-
Special Issue on Basic and Translational Research in Colorectal Cancer.Int J Mol Sci. 2019 Jun 25;20(12):3095. doi: 10.3390/ijms20123095. Int J Mol Sci. 2019. PMID: 31242580 Free PMC article.
-
Diagnostic and therapeutic biomarkers in colorectal cancer: a review.Am J Cancer Res. 2022 Feb 15;12(2):661-680. eCollection 2022. Am J Cancer Res. 2022. PMID: 35261794 Free PMC article. Review.
-
Liver Metastatic Colorectal Tumor Cells Change Their Phenotype During Consecutive Passages on Chick Embryo Chorioallantoic Membrane: Lessons from the Lab to the Clinic.In Vivo. 2021 Sep-Oct;35(5):2711-2718. doi: 10.21873/invivo.12555. In Vivo. 2021. PMID: 34410960 Free PMC article.
-
Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review.Int J Mol Sci. 2020 Jul 24;21(15):5255. doi: 10.3390/ijms21155255. Int J Mol Sci. 2020. PMID: 32722130 Free PMC article.
References
-
- Global Cancer Facts & Figures 3rd Edition. [(accessed on 12 July 2018)]; Available online: https://www.cancer.org/research/cancer-facts-statistics/global.html.
-
- Ervik M., Lam F., Ferlay J., Mery L., Soerjomataram I., Bray F. Cancer Today. [(accessed on 12 July 2018)]; Available online: http://gco.iarc.fr/today.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous